BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23423437)

  • 1. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states.
    Gui DY; Lewis CA; Vander Heiden MG
    Sci Signal; 2013 Feb; 6(263):pe7. PubMed ID: 23423437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z; Yang P; Li Z
    Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S; Liu Q; Liu T; Lu X
    J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
    Arora S; Joshi G; Chaturvedi A; Heuser M; Patil S; Kumar R
    J Med Chem; 2022 Jan; 65(2):1171-1205. PubMed ID: 34726055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of PKM2 in cancer metabolism.
    Wu S; Le H
    Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
    Li T; Han J; Jia L; Hu X; Chen L; Wang Y
    Protein Cell; 2019 Aug; 10(8):583-594. PubMed ID: 30887444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C
    Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2.
    Nandi S; Dey M
    J Biol Chem; 2020 Apr; 295(16):5390-5403. PubMed ID: 32144209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z; Wang Z; Guo W; Zhang Z; Zhao F; Zhao Y; Jia D; Ding J; Wang H; Yao M; He X
    Oncogene; 2015 Jul; 34(30):3946-56. PubMed ID: 25263439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.
    Keller KE; Doctor ZM; Dwyer ZW; Lee YS
    Mol Cell; 2014 Mar; 53(5):700-9. PubMed ID: 24606918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.
    Keller KE; Tan IS; Lee YS
    Science; 2012 Nov; 338(6110):1069-72. PubMed ID: 23086999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity.
    Verma K; Patel A
    PLoS One; 2019; 14(2):e0211515. PubMed ID: 30735509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2).
    Xu Y; Liu XH; Saunders M; Pearce S; Foulks JM; Parnell KM; Clifford A; Nix RN; Bullough J; Hendrickson TF; Wright K; McCullar MV; Kanner SB; Ho KK
    Bioorg Med Chem Lett; 2014 Jan; 24(2):515-9. PubMed ID: 24374270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule activation of PKM2 in cancer cells induces serine auxotrophy.
    Kung C; Hixon J; Choe S; Marks K; Gross S; Murphy E; DeLaBarre B; Cianchetta G; Sethumadhavan S; Wang X; Yan S; Gao Y; Fang C; Wei W; Jiang F; Wang S; Qian K; Saunders J; Driggers E; Woo HK; Kunii K; Murray S; Yang H; Yen K; Liu W; Cantley LC; Vander Heiden MG; Su SM; Jin S; Salituro FG; Dang L
    Chem Biol; 2012 Sep; 19(9):1187-98. PubMed ID: 22999886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation.
    Macpherson JA; Theisen A; Masino L; Fets L; Driscoll PC; Encheva V; Snijders AP; Martin SR; Kleinjung J; Barran PE; Fraternali F; Anastasiou D
    Elife; 2019 Jul; 8():. PubMed ID: 31264961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm.
    Liu Z; Le Y; Chen H; Zhu J; Lu D
    Front Immunol; 2021; 12():748573. PubMed ID: 34759927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
    BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Evidence for PKM2 Protein Kinase Activity.
    Hosios AM; Fiske BP; Gui DY; Vander Heiden MG
    Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.